Capturing patients’ input into clinical trials should not be a burden for patients or sites. With our cutting-edge, user-friendly technology, we provide sponsors and CROs with real-time data capture on-site or at home, and we aim to improve the overall experience of patients in clinical trials.
KAYENTIS, A GLOBAL PROVIDER OF eCOA AND DCT SOLUTIONS
A fully integrated patient-centric platform
We offer a wide range of solutions and features to manage eCOA and DCT trials.
- The most flexible set of data collection modes (Provisioned Devices – PD, BYOD, WebCOA, and remote interview mode)
- Key patient engagement features to improve the patient experience: eDiary reminder, flexible options for data entry, virtual visits, embedded media player providing relevant information
- Platform open to several levels of integration with other data collection systems (e.g., wearables)
A high-quality service for successful and streamlined trials
We aim to build strong partnerships with our clients.
- Our teams of project managers and data managers support sponsor teams throughout the project to deliver a high-quality service that is adapted to client needs.
- Our scientific and clinical team supports you through thorough protocol review and key points of attention highlight
OUR CORPORATE SOCIAL RESPONSIBILITY APPROACH
We are committed to our responsibility for the environment and to giving back to our community.
- We care about the planet
- We foster well-being at work
- We respect people and encourage diversity
- We value our community
Latest news
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement… | Read More
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement… | Read More
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating… | Read More
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of… | Read More
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally… | Read More
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement… | Read More